Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND

Journal of Diabetes and its Complications

Volumn 27, Issue 5, 2013, Pages 485-491

  Seaquist, Elizabeth R ^a   Miller, Michael E ^b   Fonseca, Vivian ^c   Ismail Beigi, Faramarz ^d   Launer, Lenore J ^e   Punthakee, Zubin ^f   Sood, Ajay ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Cognition; Diabetes; Insulin; Thiazolidinediones

Indexed keywords

HEMOGLOBIN A1C; INSULIN; PIOGLITAZONE; ROSIGLITAZONE;

ADULT; ARTICLE; BODY WEIGHT; COGNITION; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE DURATION; DRUG EXPOSURE; ENDOCRINE FUNCTION TEST; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

COGNITION; DIABETES; INSULIN; THIAZOLIDINEDIONES;

AGED; AGED, 80 AND OVER; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 84883782238     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.03.005     Document Type: Article

References (17)

1. A.M. Abbatecola, F. Lattanzio, A.M. Molinari, M. Cioffi, L. Mansi, and P. Rambaldi Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment Diabetes Care 33 2010 1706 1711
2. G.J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens Risk of dementia in diabetes mellitus: A systematic review Lancet Neurology 5 2006 64 74
3. D.E. Bonds, M.E. Miller, J. Dudl, M. Feinglos, F. Ismail-Beigi, and S. Malozowski Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data BMC Endocrine Disorders 12 2012 5
4. S. Craft Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment Current Alzheimer Research 4 2007 147 152
5. T. Cukierman-Yaffe, H.C. Gerstein, J.D. Williamson, R.M. Lazar, L. Lovato, and M.E. Miller Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial Diabetes Care 32 2009 221 226
6. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., J.T. Bigger, and J.B. Buse Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine 358 2008 2545 2559
7. M. Gold, C. Alderton, M. Zvartau-Hind, S. Egginton, A.M. Saunders, and M. Irizarry Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: Results from a randomized, double-blind, placebo-controlled phase III study Dementia and Geriatric Cognitive Disorders 30 2010 131 146
8. L.J. Launer, M.E. Miller, J.D. Williamson, R.M. Lazar, H.C. Gerstein, and A.M. Murray Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy Lancet Neurol 10 11 2011 969 977
9. S.W. MacDonald, D.F. Hultsch, E. Strauss, and R.A. Dixon Age-related slowing of digit symbol substitution revisited: What do longitudinal age changes reflect? The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 58 2003 P187 P194
10. V.N. Pavlik, S.A. de Moraes, M. Szklo, D.S. Knopman, T.H. Mosley, and P.J. Hyman Relation between cognitive function and mortality in middle-aged adults - The Atherosclerosis Risk in Communities Study American Journal of Epidemiology 157 2003 327 334
11. M. Plastino, A. Fava, D. Pirritano, P. Cotronei, N. Sacco, and T. Sperli Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2 Journal of Neurological Sciences 288 2009 112 116
12. C. Proust-Lima, H. Amieva, J.F. Dartigues, and H. Jacqmin-Gadda Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies American Journal of Epidemiology 165 2007 344 350
13. M.A. Reger, G.S. Watson, W.H. Frey II, L.D. Baker, B. Cholerton, and M.L. Keeling Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype Neurobiology of Aging 27 2006 451 458
14. C. Rosano, E.M. Simonsick, T.B. Harris, S.B. Kritchevsky, J. Brach, and M. Visser Association between physical and cognitive function in healthy elderly: The health, aging and body composition study Neuroepidemiology 24 2005 8 14
15. G.E. Swan, D. Carmelli, and A. Larue Performance on the digit symbol substitution test and 5-year mortality in the western collaborative group-study American Journal of Epidemiology 141 1995 32 40
16. G.S. Watson, B.A. Cholerton, M.A. Reger, L.D. Baker, S.R. Plymate, and S. Asthana Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study The American Journal of Geriatric Psychiatry 13 2005 950 958
17. J.D. Williamson, M.E. Miller, R.N. Bryan, R.M. Lazar, L.H. Coker, and J. Johnson The action to control cardiovascular risk in diabetes memory in diabetes study (ACCORD-MIND): Rationale, design, and methods The American Journal of Cardiology 99 2007 112I 122I